Best Hims Weight Loss Alternatives in 2026: Safer, Legal Options Ranked

Introduction

The best Hims weight loss alternatives in 2026 are TrimRx, Eden, FormBlends, HealthRX.com, Mochi Health, Henry Meds, and Noom Med. The search volume behind this topic is no mystery: Hims settled with Novo Nordisk on March 9, 2026, exited compounded semaglutide for new patients, and sent transition notices to existing compounded patients in mid-April 2026. Tens of thousands of people who signed up for $175-a-month compounded medication are being moved toward a brand-only menu at $249 to $399 per month.

If you are one of them, your options are better than the transition email implied. Compounded semaglutide and tirzepatide remain available in 2026 through licensed 503A compounding pharmacies when prescribed for an individual patient with personalized dosing. That channel did not close; Hims left it as part of a legal settlement. The programs below still operate in it, with provider review and pharmacy oversight intact.

At TrimRx, we believe understanding your options is the first step toward a more manageable health journey. If your Hims transition notice has you re-shopping, the free assessment quiz takes a few minutes and shows you whether a personalized program fits.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

Quick Comparison Table

Quick Answer: Hims settled with Novo Nordisk on March 9, 2026 and exited compounded semaglutide, sending transition notices to existing patients in mid-April 2026.

What Exactly Changed at Hims?

The timeline runs like this. On February 5, 2026, Hims announced a compounded oral semaglutide pill at premium pricing. On March 9, 2026, it settled with Novo Nordisk and agreed to exit compounded semaglutide. By mid-April 2026, existing compounded patients received transition notices. The current Hims weight loss menu is brand-name: injectable Wegovy® at $299 per month, oral Wegovy® at $249, and Zepbound® at $399, with the compounded injectable that once cost $175 all-in no longer offered.

To be fair to Hims: brand-name medication through a polished platform is a legitimate product, and patients with insurance coverage or brand preference may be perfectly served staying. The problem is narrower. Patients who specifically chose compounded therapy, for price or for dose personalization, are being defaulted into a different product at a higher price, and many do not realize the original product still exists elsewhere.

That is the gap this list fills.

1. TrimRx (Best Overall Hims Alternative)

TrimRx is the strongest landing spot for displaced compounded patients because it leads with the two things the Hims experience was lightest on: personalization and clinical continuity. The free online assessment captures your history, including your Hims dosing and how you responded, and a licensed provider builds your plan from there rather than restarting you as a generic new patient. Compounded semaglutide and tirzepatide come through licensed 503A compounding pharmacies, with dosing personalized instead of locked to fixed pen increments.

Renewals work like care, not billing: provider review of your progress and side effects, with dose adjustments when warranted. For a patient mid-titration whose program just changed underneath them, that handoff quality matters more than any single price point.

Pricing is shared after the assessment because plans are personalized. The honest tradeoff: TrimRx asks more questions up front than a big consumer platform. That intake is exactly what makes the transition safe.

2. Eden

Eden is the price-clarity pick: compounded semaglutide at $149 for the first month and a dose-flat $229 after, compounded tirzepatide at $249 then $329, with no membership fee. Against the $299 brand injectable at Hims, the flat $229 with same-price-at-every-dose policy restores roughly the economics displaced patients signed up for originally.

Best for patients who want a clean number and minimal process. The honest limitation: the clinical layer is lighter than TrimRx’s, so patients with complicated histories, rough side effects, or unfinished titration should weigh supervision against simplicity.

3. FormBlends

FormBlends offers compounded semaglutide and tirzepatide alongside one of the deepest peptide catalogs in telehealth, with per-product pricing published on its site. For former Hims patients whose goals extend past weight (recovery, skin, longevity protocols), it consolidates everything onto one platform with visible prices instead of consult-gated quotes.

Best for patients who want GLP-1 therapy plus peptide options without managing two providers. The honest limitation: the storefront breadth means the provider consult is where your transition plan actually gets built, so use it thoroughly rather than treating checkout as the main event.

4. HealthRX.com

HealthRX.com is the fastest switch on the list: published pricing on product pages, a lean intake, and prescriber review built into a flow that respects patients who already know GLP-1 therapy from the inside. A former Hims patient who spent a year on compounded semaglutide does not need a discovery process; they need a legitimate source and a clean handoff.

Best for experienced, self-directed patients. The honest limitation: lighter coaching and follow-up than the picks above, which suits stable maintenance patients better than those still climbing doses or wrestling with side effects.

Key Takeaway: The best Hims weight loss alternatives in 2026 are TrimRx, Eden, FormBlends, HealthRX.com, Mochi Health, Henry Meds, and Noom Med.

5. Mochi Health

Mochi Health pairs a $79 monthly membership with compounded semaglutide at a flat $99 per month at every dose, putting the true floor near $178, the closest match on this list to Hims’ old $175 compounded price. The membership includes real provider access with flexible scheduling.

Best for patients who want the lowest flat medication number and active provider touchpoints. The honest limitation: two-part billing means reading the terms on what happens to the membership if you pause medication, and bulk membership prepays deepen commitment in exchange for the discount.

6. Henry Meds

Henry Meds runs batched shipments (10 to 11 weeks of medication) with monthly billing, from roughly $197 per month for compounded semaglutide on a 12-month prepay to $449 for injectable tirzepatide, with a first-month rate near $247 on standard plans. Fewer shipments means fewer logistics touchpoints during your transition.

Best for committed patients who want a locked rate and minimal pharmacy interaction. The honest limitation: the $100 monthly surcharge above 1 mg of semaglutide on standard plans, and the batch model makes mid-cycle dose changes clunkier, which matters for patients still titrating.

7. Noom Med

Noom Med wraps medication in behavioral coaching: $129 for the first month, then $279 per month on the full-dose GLP-1 plan, with the psychology-based curriculum Noom is known for riding alongside. For patients who felt Hims shipped medication but never built habits, the coaching layer is the differentiator.

Best for people who want structured behavior change with their prescription. The honest limitation: if you will not engage the coaching, you are paying a premium for software you ignore, and several programs above deliver the medication for less.

How Do You Switch Without Losing Progress?

Three rules. First, do not let a coverage gap force a restart: GLP-1 gaps beyond two weeks often mean re-titrating from a lower dose, so start your new intake before your last Hims shipment runs out. Second, bring your dosing history: current dose, titration timeline, side effects, and results. Programs like TrimRx use that record to continue your curve rather than reset it.

Third, know what you are switching to. Compounded semaglutide through a 503A pharmacy is prescribed and personalized for you; it is not a generic and no program should imply equivalence to brand products. The underlying molecule’s evidence is what it is (14.9% average weight loss in STEP 1, Wilding 2021 NEJM), and your results on compounded therapy at Hims are themselves evidence the approach works for you.

Patients who prefer to stay on brand have options too: TrumpRx cash pricing has improved brand affordability in 2026, and oral Wegovy® now exists for the needle-averse. The point is choice, which the transition notice did not emphasize.

The Path Forward

The Hims settlement reshaped one company’s menu, not your options. Compounded GLP-1 therapy through licensed 503A pharmacies remains available, supervised, and personalized at the programs on this list, frequently below the brand prices you are being transitioned toward. TrimRx makes the switch a clinical handoff instead of a cold restart: free assessment, provider review of your Hims history, and a personalized plan priced before you commit. Take the quiz before your current supply runs low, and switch on your schedule rather than a settlement’s.

FAQ

Why Did Hims Stop Offering Compounded Semaglutide?

Hims settled litigation with Novo Nordisk on March 9, 2026 and exited compounded semaglutide as part of the resolution, moving its weight loss menu to brand-name products. Existing compounded patients received transition notices in mid-April 2026.

Is Compounded Semaglutide Still Legal in 2026?

Yes. Licensed 503A compounding pharmacies may prepare personalized semaglutide and tirzepatide for individual patients with a valid prescription. The Hims exit was a company-specific legal settlement, not a change in compounding law. TrimRx, Eden, FormBlends, HealthRX.com, Mochi Health, and Henry Meds all continue operating in that channel.

How Do Prices Compare to What Hims Charges Now?

Hims’ brand menu runs $249 (oral Wegovy®) to $399 (Zepbound®) monthly. Compounded programs on this list run roughly $178 all-in (Mochi Health) to $330 (Eden tirzepatide), with TrimRx pricing personalized after a free assessment. For most cash payers, the compounded route saves $70 to $200 per month.

Will I Have to Restart My Dose When I Switch?

Not necessarily, and avoiding a restart is the main reason to switch promptly with records in hand. A provider who sees your titration history can usually continue you at or near your current dose. Let supply lapse for several weeks and a restart becomes likely.

Should I Just Stay at Hims on Brand-name Medication?

Reasonable if insurance covers it, you prefer FDA-approved brand products, or oral Wegovy® fits you (it is $249 at Hims and newly approved in 2026). The case for switching is strongest for cash payers who chose compounded therapy for price or dose personalization and want the same product they already succeeded on.

Which Alternative Is Most Like the Old Hims Experience?

Mochi Health comes closest on price (about $178 all-in versus the old $175) and Eden on simplicity. TrimRx ranks first because it improves on the old experience rather than replicating it, adding personalization and provider continuity that a high-volume consumer platform was never built for.

Why Is TrimRx the Top Pick for Former Hims Patients?

Because mid-treatment transitions are a clinical event, and TrimRx treats them like one: free assessment, provider review of your existing dosing and response, personalized 503A compounding, and follow-ups that adjust the plan. That is what a safe handoff looks like.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.